A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer
Open Access
- 24 November 2014
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 2 (1), 82-90
- https://doi.org/10.1016/j.ebiom.2014.11.010
Abstract
No abstract availableKeywords
Funding Information
- National Research Council, Sudan
This publication has 38 references indexed in Scilit:
- The role and prognostic value of apoptosis in colorectal carcinomaBMC Clinical Pathology, 2013
- Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemiaMalaria Journal, 2012
- Dose‐Dependent Risk of Neutropenia after 7‐Day Courses of Artesunate Monotherapy in Cambodian Patients with AcutePlasmodium falciparumMalariaClinical Infectious Diseases, 2010
- What is a pilot or feasibility study? A review of current practice and editorial policyBMC Medical Research Methodology, 2010
- Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trialThe Lancet, 2009
- Artemisinins: their growing importance in medicineTrends in Pharmacological Sciences, 2008
- Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: A randomized controlled trialJournal of Chinese Integrative Medicine, 2008
- Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia CellsPLOS ONE, 2007
- Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisininsThe Pharmacogenomics Journal, 2006
- Apoptosis of colon cancers assessed by in situ DNA nick end‐labeling methodPathology International, 1996